NCT03260023 2026-02-05Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M CancersTransgenePhase 1/2 Active not recruiting143 enrolled 24 charts
NCT02813135 2026-01-16ESMARTGustave Roussy, Cancer Campus, Grand ParisPhase 1/2 Recruiting472 enrolled
NCT04266912 2025-11-25Avelumab and M6620 for the Treatment of DDR Deficient Metastatic or Unresectable Solid TumorsM.D. Anderson Cancer CenterPhase 1/2 Active not recruiting23 enrolled 11 charts